You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 271 No. 6, February 9, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

The use of serologic tests for Lyme disease in a prepaid health plan in California

C. Ley, C. Le, E. M. Olshen and A. L. Reingold
Epidemiology Program, School of Public Health, University of California, Berkeley 94720.

OBJECTIVE--To determine the reason(s) why serologic tests for Lyme disease are performed, who initiates the test requests, and how the test results are used in a clinical setting. DESIGN--Retrospective cohort. SETTING--Prepaid health plan in northern California. PATIENTS--Consecutive sample of 117 patients for whom at least one serologic test for Lyme disease was performed during a 3-month period. MAIN OUTCOME MEASURES--Reason for ordering and result of the serologic test, differential diagnoses, and treatment. RESULTS--One of 117 patients had antibodies to Borrelia burgdorferi. Fifty-six percent of test requests were initiated by the physician and 35% by the patient. Of 66 tests ordered by the physician, 20% were performed because of suspected early Lyme disease, 6% as follow-up of a tick bite, 2% to confirm a prior history of Lyme disease, 14% as a workup for arthritis, and 60% as one of a battery of laboratory tests for vague symptoms. Of 41 tests initiated by the patient, 51% were performed because of a history of a tick bite. The reasons for ordering 10 tests were undetermined. CONCLUSION--Only 19% of all serologic tests for Lyme disease were performed because the physician suspected Lyme disease in the patient. Particularly in light of the low probability of contracting Lyme disease in California, it appears that this serologic test is being overused. Indiscriminate testing increases health care costs and does not appear to affect treatment decisions. Education is needed regarding the limitations of this serologic test.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Appropriateness of Lyme Disease Serologic Testing
Ramsey et al.
Ann Fam Med 2004;2:341-344.
ABSTRACT | FULL TEXT  

Use of Serum Immune Complexes in a New Test That Accurately Confirms Early Lyme Disease and Active Infection with Borrelia burgdorferi
Brunner and Sigal
J. Clin. Microbiol. 2001;39:3213-3221.
ABSTRACT | FULL TEXT  

Do We Know What Inappropriate Laboratory Utilization Is?: A Systematic Review of Laboratory Clinical Audits
van Walraven and Naylor
JAMA 1998;280:550-558.
ABSTRACT | FULL TEXT  

Tick Bites and Lyme Disease in an Endemic Setting: Problematic Use of Serologic Testing and Prophylactic Antibiotic Therapy
Fix et al.
JAMA 1998;279:206-210.
ABSTRACT | FULL TEXT  

Expert Advice and Patient Expectations: Laboratory Testing and Antibiotics for Lyme Disease
Barbour
JAMA 1998;279:239-240.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.